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Abstract
Background: Carcinoid tumors rarely arise in the extrahepatic bile duct and can be difficult to
distinguish from carcinoma. There are no reports of clear cell carcinoid (CCC) tumors in the distal
bile duct (DBD) to the best of our knowledge. Herein, we report a CCC tumor in the DBD and
review the literature concerning extrahepatic bile duct carcinoid tumors.
Case presentation: A 73-old man presented with fever and occult obstructive jaundice.
Ultrasonography, computed tomography (CT) and magnetic resonance
cholangiopancreaticography (MRCP) demonstrated a nodular tumor projection in the DBD
without regional lymph node swelling. Under suspicion of carcinoma, we resected the head of the
pancreas along with 2nd portion duodenectomy and a lymph node dissection. The surgical specimen
showed a golden yellow polypoid tumor in the DBD (0.8 × 0.6 × 0.5 cm in size). The lesion was
composed of clear polygonal cells arranged in nests and a trabecular pattern. The tumor invaded
through the wall into the fibromuscular layer. Immunohistochemical stains showed that neoplastic
cells were positive for neuron-specific enolase (NSE), chromogranin A, synaptophysin, and
pancreatic polypeptide and negative for inhibin, keratin, CD56, serotonin, gastrin and somatostatin.
The postoperative course was uneventful and he is living well without relapse 12 months after
surgery.
Conclusion: Given the preoperative difficulty in differentiating carcinoid from carcinoma, the
pancreaticoduodenectomy is an appropriate treatment choice for carcinoid tumors located within
the intra-pancreatic bile duct.
Background
Extrahepatic bile duct carcinoid tumors are extraordinar-
ily rare lesions and account for only 0.32% of all carci-
noids of the gastrointestinal tract [1]. Since 1961 when
Pilz described the first carcinoid tumor arising from the
common bile duct, only 51 cases have been described,
excluding the ampulla of Vater, cystic duct, gallbladder
and intrahepatic bile ducts. In particular, the morpholog-
ically distinct primary clear cell carcinoid tumor of the ext-
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report to the best of our knowledge.
We report herein a clear cell carcinoid tumor of arising
from the distal (intra-pancreatic portion) common bile
duct as the first report of a clear cell carcinoid tumor of the
extrahepatic bile duct. Because of the rarity of carcinoid
tumors in the bile duct as well as the rarity of clear cell car-
cinoid tumors, it is difficult to adequately assess their
malignant potential, their responsiveness to particular
treatments and their overall prognosis. Improved under-
standing can only be obtained by analyzing the collected
data from reported cases; accordingly, we reviewed the lit-
erature concerning carcinoid tumors originating from the
extrahepatic bile ducts.
Case presentation
A 73-old man was visited our hospital with high fever
(39°C), epigastric pain and reduced consciousness. He
had suffered from poorly controlled diabetes mellitus,
hypertension and multiple brain infarctions during the
previous 3 years. On physical examination, no abdominal
mass was palpable. Laboratory tests revealed signs of
inflammation, including a WBC count of 34,400/mm3
and a CRP 10.4 of mg/dl, and abnormal liver function
results with signs of biliary obstruction (AST/ALT 418/479
IU/L, ALP 591IU/L, γGTP 1041 IU/L, and TBL/DBL 4.2/
2.9 mg/dl). The tumor markers were within the normal
range: CEA 4.0 ng/ml and CA19-9 128 U/ml (slight eleva-
tion). The patient's blood sugar was elevated at 311 mg/dl
with an elevated HbA1C of 7.9%, but no ketone bodies
were detected in the urine. Contrast-enhanced abdominal
CT revealed a slight dilatation of the intra/extra-hepatic
bile ducts, a slightly enhanced protruding nodular lesion
in the intra-pancreatic common bile duct and no lymph
node swelling neither around the head of pancreas nor
within the hepato-duodenal ligament. Ultrasonography
demonstrated a slightly thickened gallbladder wall with-
out calculi. Endoscopic retrograde cholangiopancreatog-
raphy (ERCP) and MRCP showed a nodular mass with an
irregular surface protruding into the bile duct lumen from
the left wall at the distal end of the common bile duct (Fig.
1A&1B ). Abdominal arteriography and portography
demonstrated no abnormalities and we carried out surgi-
cal resection with suspicion of carcinoma less than stage II
of the intra-pancreatic bile duct.
During laparotomy, a polypoid lesion was palpated in the
common bile duct at the head of the pancreas. However,
whether tumor was invading the pancreas or not was
unclear and regional nodes were soft and slightly swollen.
Given the suspicion of distal bile duct carcinoma without
node metastasis (less than stage II); the patient underwent
a modified pancreaticoduodenectomy. Taking into
account possible complications, we tried to preserve not
only the pylorus, but also the first and third portions of
the duodenum and performed a regional lymphadenec-
tomy.
Macroscopically, the surgical specimen showed a golden
yellowish polypoid mass, measuring 1.0 × 1.2 × 0.7 cm in
size that was projecting from the surface of the intra-pan-
creatic portion of the bile duct. The superficial yellow dis-
coloration extended to the proximal epithelium from the
tumor base. The thickening of the bile duct wall at the
tumor bed suggested longitudinal and vertical tumor
invasion (Figure 2). Histologically, the tumor consisted of
fairly uniformly sized polygonal cells, with small round
nuclei, inconspicuous nucleoli, and clear abundant cyto-
plasm. The neoplastic cells were arranged in combination
patterns with tubular or trabecular anastomozing struc-
tures and solid nests. The tumor cells penetrated the fibro-
Cholangiographies: A and B)Figure 1
Cholangiographies: A and B). Endoscopic retrograde cholangiopancreatography (ERCP) and C). Magnetic resonance cholan-
giopancreatography (MRCP) showing a nodular mass protruding into the bile duct lumen from the left wall at the distal end of 
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surrounding pancreatic parenchyma (Figure 3). Mitotic
figures were not visible. There were no necrotic areas and
no vascular invasion, but there was limited perineural
invasion and were questionable areas of lymphovascular
invasion. The regional lymph nodes and resection mar-
gins were negative for tumor cell invasion. Tumor cells
showed positive staining for Grimelius silver. Immuno-
histochemical stains were positive for various neuroendo-
crine markers as chromogranin A, synaptophysin,
neuron-specific-enolase, and pancreatic polypeptide (Fig.
4). However, inhibin, keratin, CD56, somatostatin, serot-
onin, and gastrin were negatively stained. Based on these
findings, we diagnosed the patient with a clear cell carci-
noid tumor of the distal (intra-pancreatic) common bile
duct. The postoperative course was uneventful and the
patient is well with no evidence of relapse 12 months after
surgery.
Discussion
Recently, the World Health Organization (WHO) devel-
oped a new classification system that gives a better
description of the characteristics and biological behavior
of the carcinoid tumors. These tumors can be malignant
and the histopathological differentiation of carcinoid
tumors ranges from well differentiated (traditionally
known as carcinoid tumors) to poorly differentiated
malignancies with neuroendocrine features, typified by
small cell carcinoma. Carcinoid tumors derived from neu-
roendocrine cell compartments and their frequency of
occurrence correlate with the site-density of neuroendo-
crine cells. Most (over 60%) of carcinoid tumors arise
from the gastrointestinal system, followed by the bron-
chopulmonary system (25%). Carcinoid tumors of the
extrahepatic bile duct, excluding Vater, intrahepatic bile
duct, gallbladder and cystic duct, are extremely rare. The
incidence in all gastrointestinal carcinoid tumors is
0.32%, according to the recent analysis of 13,715 carci-
noid tumors [1]. On the other hand, more than 80% of
the extrahepatic bile duct tumors are adenocarcinomas
[2,3]. Carcinoid tumors are slow-growing malignancies,
as was first emphasized by the use of the term "carcinoid"
in 1907, referring to the benign nature of the tumor [4].
Pilz reported the first case of a carcinoid tumor of the
common bile duct in 1961 [5]; thereafter, 51 cases of ext-
rahepatic bile duct carcinoid tumors, excluding composite
tumors with carcinoma, have been reported in the litera-
ture (See Additional file 1). Reports by Davies [6] and
Godwin [7] were excluded because of the lack of detail.
Exploring the original site of the tumor in detail, only 11
cases were found to have arisen from the intra-pancreatic
(distal) portion (DBD), 14 cases arose in the middle por-
tion (MBD) and the remaining 26 cases arose in the prox-
imal bile ducts (PBD), including the right, left and
common hepatic ducts (see additional file 1).
Only two clear cell carcinoid (CCC) tumors of the gall-
bladder have been described as originating from the bil-
iary tracts; however, there have been no case reports of
CCCs arising from the extrahepatic bile ducts. One case
has been interpreted to be a CCC tumor of the gallbladder
and appeared to be a distinctive manifestation of von Hip-
pel-Lindau (VHL) disease with diffuse expression of
inhibin in the tumor [8]. Those authors hypothesized that
inhibin may be a product of CCC tumors associated with
VHL disease and a useful marker in distinguishing these
from metastatic renal cell carcinomas. On the other hand,
in another case the patient's tumor was not associated
with VHL disease and the CCC tumor had negative expres-
sion of inhibin [9]. In our case, the CCC tumor was also
negative for inhibin without any correlation to VHL dis-
ease. Although further investigations of inhibin expres-
sion in CCC tumors of the biliary tract with and without
VHL disease are required, Sinkre's hypothesis is an inter-
esting in suggesting a biomarker to detect concomitant
VHL disease.
Carcinoid tumors are composed of multipotential cells
with the ability to secrete numerous hormonal substances
and vasoactive peptides. These substances cause the clini-
cal features that constitute carcinoid syndrome; however,
within the extrahepatic bile duct, only one carcinoid
tumor has been associated with the syndrome [10]. The
most popular symptom for extrahepatic bile duct carci-
noids was obstructive jaundice, accounting for 75 percent
of the reported cases. From the viewpoint of treatment,
the prime concern is the location of the tumor and the
The surgical specimen showed a golden yellowish polypoid mass (arrow), measuring 1.0 × 1.2 × 0.7 cm in s ze, rojecting from the surface of the intra-pancreatic portion of the bileductFigure 2
The surgical specimen showed a golden yellowish polypoid 
mass (arrow), measuring 1.0 × 1.2 × 0.7 cm in size, projecting 
from the surface of the intra-pancreatic portion of the bile 
duct. DU: duodenum, PNC: pancreas head, CBD: common 
bile duct, GB: gallbladderPage 3 of 7
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than the presence of the carcinoid syndrome. When the
distal (intra-pancreatic) bile duct is affected, surgery
should consist of a head of pancreas resection with a
whole duodenectomy (pancreaticoduodenectomy) or a
resection of the second portion of the duodenum, as well
as pyloric preservation to achieve adequate radicality. In
our case, a pancreatic head resection with a 2nd portion
duodenectomy was successfully performed with an en bloc
resection of the tumor and surrounding structures includ-
ing regional lymph nodes. In the event of middle to prox-
imal bile duct involvement, an en bloc excision of the bile
ducts from the main hepatic ducts down to the upper mar-
gin of the pancreas and adjoining lymph nodes (with con-
struction of a Roux-en-Y hepaticojejunostomy or
hepaticoduodenostomy) will be appropriate to preserve
the patient's prospects for a cure.
Accurate pre-and intra-operative histological diagnosis
may be problematic because the discrimination between
carcinoid tumors and carcinoma is difficult at times, par-
ticularly with frozen section specimens. In some cases,
frozen section diagnosis is inconclusive and resection
must be undertaken with an indeterminate diagnosis. In
our case, cytological examination failed to demonstrate
carcinoid cells. However, imaging diagnostic findings
obtained from CT, MRCP and ERCP and abdominal ang-
iography were actually regarded as sufficient evidence to
precede radical surgery since those images demonstrated a
protruding nodular tumor in the distal bile duct and no
evidence of metastasis in the regional nodes, distant
metastasis and vascular involvement.
Carcinoid tumors are slow-growing malignancies; how-
ever, prognosis after treatment depends on the evidence of
degree of malignancy. Mitotic counts and the degree of
anaplasia cannot reliably determine malignancy; rather, it
is microscopic local invasion or gross distant spreads that
differentiate the benign from the malignant forms of this
disease. Metastases to distant organs (chiefly the liver),
regional lymph nodes and direct invasion into the
perineural lymph space, microscopic vessels and adjacent
structures were found in 21 of 49 reported cases (includ-
ing our case and excluding three cases which lacked ade-
quate information). Out of those 21 patients with
extended tumors, only two deaths)[11,12] were directly
attributable to progression of the carcinoid tumors after
radical surgery, although one patient died from its tumor
one day after celiotomy for carcinoidomatosis [13]. On
the other hand, one patient with a liver metastasis and 15
patients with loco-regional extension are living well 18
months later [14], and from 6 months to 20 years [15]
Photomicrographs stained by Hematoxylin and EosinFigure 3
Photomicrographs stained by Hematoxylin and Eosin. A: Tumor cells penetrating the fibromuscular layer of the bile 
duct, but not reaching to the surrounding pancreatic parenchyma. (Original magnification ×200). B: Tumor consisting of fairly 
uniform polygonal cells in size, with round nuclei and clear and abundant cytoplasm. Neoplastic cells are arranged in combina-
tion patterns with solid nests and trabecular growth. Preexisting non-neoplastic gland is entrapped in the lesion. (Original mag-
nification ×400)Page 4 of 7
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file 1). The details of earlier reported case are illustrated in
additional file 1[16-52]. However, because of the rarity of
carcinoid tumors of the bile ducts, it is difficult to accu-
rately and adequately assess the natural history of this dis-
ease, the malignant potential of the tumors, their
responsiveness to particular treatments, and the overall
prognosis after different types of therapy. This can only be
achieved with continued reporting of cases in detail.
Conclusion
Definite diagnosis is difficult preoperatively but may be
improved with the assessment of neuroendocrine markers
in suspected cases. Disease-free survival is prolonged fol-
lowing complete and safe resection of the tumor. Because
carcinoid tumors are slow growing and less aggressive
than adenocarcinoma, even if these patients have metas-
tases, they should be treated aggressively. Continued
reporting of single cases and long-term follow-up should
be encouraged with reporting of the results of treatment.
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Tumor cells were stained by Grimelius silver (A), and positive for immunohistochemical staining of Chromogranin-A (B) and for Synaptophysin (C)Figure 4
Tumor cells were stained by Grimelius silver (A), and positive for immunohistochemical staining of Chromogranin-A (B) and 
for Synaptophysin (C). Clear cells were completely negative for Keratin, but positive in the intercalated non-neoplastic glands 
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